Shockwave Medical, Inc. Common Stock
SWAV
SWAV was delisted on the 30th of May, 2024.
458 hedge funds and large institutions have $9.33B invested in Shockwave Medical, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 121 funds opening new positions, 114 increasing their positions, 175 reducing their positions, and 42 closing their positions.
188% more first-time investments, than exits
New positions opened: 121 | Existing positions closed: 42
28% more capital invested
Capital invested by funds: $7.31B → $9.33B (+$2.02B)
20% more funds holding
Funds holding: 381 → 458 (+77)
17% less call options, than puts
Call options by funds: $134M | Put options by funds: $162M
25% less funds holding in top 10
Funds holding in top 10: 8 → 6 (-2)
35% less repeat investments, than reductions
Existing positions increased: 114 | Existing positions reduced: 175
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$241M |
| 2 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$103M |
| 3 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
+$85.7M |
| 4 |
Millennium Management
New York
|
+$79.9M |
| 5 |
Canada Pension Plan Investment Board
Toronto Ontario,
Ontario, Canada
|
+$47.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$245M |
| 2 |
JP Morgan Chase
New York
|
-$122M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$84.3M |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$75.9M |
| 5 |
Envestnet Asset Management
Chicago,
Illinois
|
-$69.7M |
SWAV Hedge Fund Activity: Q2 2023 in Review
458 of the 6,383 institutional investors tracked by Wall St. Rank reported a position in Shockwave Medical, Inc. Common Stock (SWAV) for Q2 2023, worth a combined $9.33B — up 28% from $7.31B a quarter earlier.
Buyers outnumbered sellers: 121 funds opened new SWAV positions and 42 closed out — a net gain of 79 holders — while 114 added to existing stakes and 175 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $241M. The largest seller was BlackRock, cutting an estimated $245M.
- 458 institutional investors held Shockwave Medical, Inc. Common Stock (SWAV) as of Q2 2023, up from 381 in Q1 2023.
- Funds reported $9.33B of Shockwave Medical, Inc. Common Stock stock for Q2 2023, up 28% quarter-over-quarter.
- 121 funds opened new Shockwave Medical, Inc. Common Stock positions in Q2 2023 and 42 closed out, a net change of +79 holders.
- The largest Shockwave Medical, Inc. Common Stock buyer in Q2 2023 was Wellington Management Group, an estimated $241M added.
- The largest Shockwave Medical, Inc. Common Stock seller in Q2 2023 was BlackRock, an estimated $245M sold.
Based on aggregated 13F filings for Q2 2023.